CVE-2008-6087
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote...
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote attackers to inject arbitrary web script or HTML via the name parameter.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote attackers to inject arbitrary web script or HTML via the name parameter.
- Record
CVE-2008-6087- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote attackers to inject arbitrary web script or HTML via the name parameter.
- Record
CVE-2008-6087- Updated
- 2026-11-02
EUVDEUVD-2008-6057 No score
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote attackers to inject arbitrary web script or HTML via the name parameter.
- Record
EUVD-2008-6057- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-mw8v-rjj4-5wq9 No score
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote...
Cross-site scripting (XSS) vulnerability in topic.php in Camera Life 2.6.2b4 allows remote attackers to inject arbitrary web script or HTML via the name parameter.
- Record
GHSA-mw8v-rjj4-5wq9- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | Camera Life 2.6.2b4 - SQL Injection / Cross-Site Scripting | 2008-10-09 |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, Exploit-DB, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2008-6087 is a medium vulnerability (CVSS 4.3) in Camera Life Life, published February 6, 2009. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 1.60%, the 75th percentile. No source names a fixed version.